7-aminoactinomycin d has been researched along with Breast Cancer in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Alsherbiny, MA; Bhuyan, DJ; Chang, D; Li, CG; Low, MN | 1 |
Dudek, AZ; Jasinski, P; Terai, K; Zwolak, P | 1 |
2 other study(ies) available for 7-aminoactinomycin d and Breast Cancer
Article | Year |
---|---|
Synergistic Interactions of Cannabidiol with Chemotherapeutic Drugs in MCF7 Cells: Mode of Interaction and Proteomics Analysis of Mechanisms.
Topics: Adenocarcinoma; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Breast Neoplasms; Cannabidiol; Cell Line, Tumor; Cell Survival; Dactinomycin; Docetaxel; Doxorubicin; Drug Screening Assays, Antitumor; Drug Synergism; Female; Humans; Irinotecan; MCF-7 Cells; Paclitaxel; Proteome; Proteomics; Vinorelbine | 2021 |
Enzastaurin renders MCF-7 breast cancer cells sensitive to radiation through reversal of radiation-induced activation of protein kinase C.
Topics: Annexin A5; Apoptosis; Blotting, Western; Breast Neoplasms; Caspase 3; Caspase 9; Cell Survival; Cytosol; Dactinomycin; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Gamma Rays; Humans; Indoles; Phosphorylation; Protein Kinase C; Radiation-Sensitizing Agents; Repressor Proteins; Tumor Cells, Cultured | 2008 |